|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2015
12 months to Mar 31, 2016
|
FY2014
12 months to Mar 31, 2015
|
FY2013
12 months to Mar 31, 2014
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash equity based compensation | |||||
| Recovery of impaired assets | |||||
| Gain on sale of long-lived assets | |||||
| Impairment of inventories | |||||
| Change in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Other receivable | |||||
| Costs and estimated earnings on uncompleted contracts | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable and other current liabilities | |||||
| Unearned revenue | |||||
| Billings in excess of costs and estimated earnings on engineering services contracts | |||||
| Other long-term liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisition of property and equipment, net | |||||
| Cash paid for patent and trademark fees | |||||
| Cash proceeds from the sale of long-lived assets | |||||
| Net cash (used in) provided by investing activities | |||||
| Net cash (used in)/ provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Cash received for shares exercised under employee stock purchase plan | |||||
| Proceeds from line of credit | |||||
| Payment of employee tax withholdings in exchange for return of common stock | |||||
| Net cash (used in) provided by financing activities | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Issuance of common stock upon definitive stock purchase agreement | |||||
| Issuance of common stock upon exercise of employee and directors options | |||||
| Net cash provided by financing activities | |||||
| Increase / (decrease) in cash, cash equivalents, and restricted cash | |||||
| (Decrease)/ increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
Loading...